[1] Reddy SM, Kumar Vadivel J, Ramalingam K, et al. Prevalence of aphthous stomatitis: a cross-sectional epidemiological study[J]. Cureus, 2023, 15(11):e49288. [2] Aktas H, Bakkaloglu O. Management of recurrent aphthous stomatitis in clinical practice: a review of treatment variability and challenges[J]. J Oral Pathol Med, 2020, 49(8):723-730. [3] Seo HR, Chung KB, Kim DY, et al. The possible impact of zinc-enriched multivitamins on treatment-naïve recurrent aphthous stomatitis patients[J]. Clin Med, 2025, 14(1):260. [4] Lau CB, Smith GP. Recurrent aphthous stomatitis: a comprehensive review and recommendations on therapeutic options[J]. Dermatol Ther, 2022, 35(6):e15500. [5] Cheng YO, Veettil SK, Syeed MS, et al. Comparative efficacy of therapeutic interventions for the management of recurrent aphthous ulcers: A systematic review and network meta-analysis[J]. Evid Based Dent Pract, 2023, 23(4):101918. [6] 陈谦明.口腔黏膜病学[M].第5版.北京:人民卫生出版社,2020:53-58. [7] Scully C, Gorsky M, Lozada-Nur F, et al. The diagnosis and management of recurrent aphthous stomatitis: a consensus approach[J]. J Am Dent Assoc, 2003, 134(2):200-207. [8] Conejero Del Mazo R, García Forcén L, Navarro Aguilar ME, et al. Recurrent aphthous stomatitis[J]. Med Clin (Barc), 2023, 161(6):251-259. [9] Liu H, Tan L, Fu G, et al. Efficacy of topical intervention for recurrent aphthous stomatitis: A network meta-analysis[J]. Medicina (Kaunas), 2022, 58(6):771. [10] Conejero Del Mazo R, García Forcén L, Navarro Aguilar ME. Recurrent aphthous stomatitis[J]. Med Clin (Barc), 2023, 161(6):251-259. [11] Liu Z, Liu X, Han Y, et al. Efficacy and safety of total glucosides of paeony in the treatment of recurrent aphthous ulcers: a systematic review and meta-analysis[J]. Front Pharmacol, 2024, 15:1378782. [12] Ye Y, Wu J, Dai Y, et al. Psychological problems and their impact on oral mucosal disease patients' quality of life: a cross-sectional study in the Chinese population[J]. Heliyon, 2024, 10(19):e38210. [13] Liu Z, Lu M, Wang W, et al. Anxiety and small intestinal bacterial overgrowth: associations with recurrent aphthous ulcers[J]. BMC Oral Health, 2025, 25(1):688. [14] Dong Y, Lou F, Yan L, et al. Salivary microbiota and metabolic phenotype of patients with recurrent aphthous ulcers[J]. Oral Dis, 2024, 30(7):4412-4425. [15] Ghasemi S, Farokhpour F, Mortezagholi B, et al. Systematic review and meta-analysis of oxidative stress and antioxidont markers in recurrent aphthous stomatitis[J]. BMC Oral Health, 2023, 23(1):960. [16] Saikaly SK, Saikaly TS, Saikaly LE, et al. Recurrent aphthous ulceration: a review of potential causes and novel treatments[J]. J Dermatolog Treat, 2018, 29(6):542-552. [17] 中华口腔医学会口腔黏膜病专业委员会,中华口腔医学会中西医结合专业委员会,周刚.复发性阿弗他溃疡诊疗指南(试行)[J].中华口腔医学杂志,2012,47(7): 402-404. [18] Fekrazad R, Gholami GA, Sadr Eshkevari P, et al. Management of recurrent aphthous ulcers with therapeutic Nd:YAG laser, using two different methods[J]. Dent Med Probl, 2023, 60(3):467-472. [19] Parra-Moreno FJ, Egido-Moreno S, Schemel-Suárez M, et al. Treatment of recurrent aphthous stomatitis: a systematic review[J]. Med Oral Patol Oral Cir Bucal, 2023, 28(1):e87-e98. [20] Suda T, Fujii H. Beta blocker-induced recurrent aphthous stomatitis[J]. Intern Med, 2023, 62(6):57. [21] Mousavi T, Jalali H, Moosazadeh M, et al. Hematological parameters in patients with recurrent aphthous stomatitis: a systematic review and meta-analysis[J]. BMC Oral Health, 2024, 24(1):339. [22] Zeng Q, Shi X, Yang J, et al. The efficacy and safety of thalidomide on the recurrence interval of continuous recurrent aphthous ulceration: a randomized controlled clinical trial[J]. J Oral Pathol Med, 2020, 49(4):357-364. [23] Al-Zainal Z, Farid Ashraf S, Gopinath D, et al. Clinical efficacy of lasers in the management of recurrent aphthous ulcers of oral cavity: a systematic review of randomized control trials[J]. Lasers Med Sci, 2025, 40(1):49. [24] Ebrahimnia M, Rabbani S, Mahboubi A, et al. Preparation, antioxidant, antibacterial, and in vivo evaluation of pomegranate flower extract nanofibers based on thiolated chitosan and thiolated gelatin for treating aphthous stomatitis[J]. Carbohydr Polym, 2025, 351:122971. [25] Smith J, Brown L. Use of anti-TNF-α therapy in the management of oral ulcers: a review of the literature[J]. J Oral Pathol Med, 2020, 49(6):456-463. [26] Liu D, Zhang T, Zhou H, et al. Role of biologics in refractory recurrent aphthous stomatitis[J]. J Oral Pathol Med, 2022, 51(8):694-701. [27] Calder PC. Omega-3 fatty acids and inflammatory processes: from molecules to man[J]. Biochem Soc Trans, 2017, 45(5):1105-1115. [28] Zhu M, Mao X, Huang X, et al. Novel serum markers that distinguish Behcet's disease from idiopathic recurrent aphthous stomatitis[J]. Immunol Invest, 2025, 54(1):1-17. [29] Rivera C, Muñoz-Pastén M, Núñez-Muñoz E, et al. Recurrent aphthous stomatitis affects quality of life: A case-control study[J]. Clin Cosmet Investig Dent, 2022, 14:217-223. [30] Mashrah MA, Fang Y, Song W, et al. Topical medications for the treatment of recurrent aphthous stomatitis: A network meta-analysis[J]. J Oral Pathol Med, 2023, 52(9):811-825. |